CCR5 antagonist TD-0680 uses a novel mechanism for enhanced potency against HIV-1 entry, cell-mediated infection, and a resistant variant

Yuanxi Kang, Zhiwei Wu, Terrence C.K. Lau, Xiaofan Lu, Li Liu, Allen K.L. Cheung, Zhiwu Tan, Jenny Ng, Jianguo Liang, Haibo Wang, Saikam Li, Bojian Zheng, Ben Li, Li Chen, Zhiwei Chen*

*Corresponding author for this work

Research output: Contribution to journal › Journal article › peer-review

18 Citations (Scopus)

Fingerprint

Dive into the research topics of 'CCR5 antagonist TD-0680 uses a novel mechanism for enhanced potency against HIV-1 entry, cell-mediated infection, and a resistant variant'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds